Pancreatic Cancer Research

ResearcherTranslational Genomics Research InstituteActive in the last 2 years

Richard Matthew Walsh

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8937-2702; OpenAlex author ID A5090355450. Sources: OpenAlex.

Their work

Papers
15 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
27
Papers, trials and grants by year

2014: 1 paper · 2015: 1 paper · 2016: none · 2017: 2 papers · 2018: none · 2019: 2 papers · 2020: none · 2021: 2 papers · 2022: none · 2023: 2 papers · 2024: 2 papers · 2025: none · 2026: 3 papers

Papers 15

  1. Comparing Palliative Approaches for GOO in Locally Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis. Co-author DOI 10.1002/jso.70131↗
  2. The Practices of Pancreatic Neck Margin Testing and Their Outcomes after Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1245/s10434-026-20092-7↗
  3. ASO Visual Abstract: The Practices of Pancreatic Neck Margin Testing and Their Outcomes After Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1245/s10434-026-20242-x↗
  4. Comparing oncologic and surgical outcomes of robotic and laparoscopic pancreatoduodenectomy in patients with pancreatic cancer: a propensity-matched analysis. Co-author DOI 10.1007/s00464-024-10783-1↗
  5. Tumor Size Combined With CA-19 Level Improves Prediction of Survival of Patients With Pancreatic Adenocarcinoma Undergoing Perioperative Chemotherapy and Resec… Co-author DOI 10.1177/00031348241241738↗
  6. The role of minimally invasive surgery in resectable distal pancreatic adenocarcinoma. Co-author DOI 10.1016/j.hpb.2023.06.003↗
  7. Utility of endoscopic ultrasound for assessment of locoregional recurrence of pancreatic adenocarcinoma after surgical resection. Co-author DOI 10.1055/a-2046-4984↗
  8. Survival impact based on hepatic artery lymph node status in pancreatic adenocarcinoma: A study of patients receiving modern chemotherapy. Co-author DOI 10.1002/jso.26281↗
  9. Neoadjuvant chemoradiation is associated with decreased lymph node ratio in borderline resectable pancreatic cancer: A propensity score matched analysis. Last author DOI 10.1016/j.hbpd.2020.08.001↗
  10. Pathologic tumor response to neoadjuvant therapy in borderline resectable pancreatic cancer. Co-author DOI 10.1016/j.hbpd.2019.05.007↗
  11. Next-Generation Sequencing in Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000001324↗
  12. Diagnostic Laparoscopy Prior to Neoadjuvant Therapy in Pancreatic Cancer Is High Yield: an Analysis of Outcomes and Costs. Co-author DOI 10.1007/s11605-017-3470-6↗
  13. Neoadjuvant chemoradiation for non-metastatic pancreatic cancer increases margin-negative and node-negative rates at resection. Co-author DOI 10.1111/1751-2980.12551↗
  14. Predicting early mortality in resectable pancreatic adenocarcinoma: A cohort study. Co-author DOI 10.1002/cncr.29298↗
  15. Pancreatic adenocarcinoma: treating a systemic disease with systemic therapy. First author DOI 10.1093/jnci/dju011↗

Closest collaborators

The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Toms Augustin · 7 shared papers, 2021–2026 · strength 1.44
  2. Samer A. Naffouje · 6 shared papers, 2023–2026 · strength 1.31
  3. Chase J. Wehrle · 5 shared papers, 2024–2026 · strength 1.13
  4. Kathryn A. Stackhouse · 5 shared papers, 2023–2026 · strength 1.10
  5. Jenny H. Chang · 5 shared papers, 2023–2026 · strength 1.07
  6. Kimberly P. Woo · 3 shared papers, 2024–2026 · strength 0.68
  7. Gareth J Morris‐Stiff · 5 shared papers, 2015–2021 · strength 0.52
  8. Sricharan Chalikonda · 4 shared papers, 2015–2021 · strength 0.38
  9. Fadi S. Dahdaleh · 2 shared papers, 2023–2024 · strength 0.37
  10. Breanna C. Perlmutter · 2 shared papers, 2021–2024 · strength 0.34
  11. June S. Peng · 3 shared papers, 2017–2021 · strength 0.33
  12. Rob Naples · 1 shared paper, 2026 · strength 0.24
  13. Asad Gul Rao · 1 shared paper, 2026 · strength 0.24
  14. Sayf Al-deen Said · 1 shared paper, 2024 · strength 0.21
  15. Alok A. Khorana · 3 shared papers, 2014–2017 · strength 0.19
  16. Jason W. Denbo · 1 shared paper, 2023 · strength 0.18
  17. Carlos Roberto Simons-Linares · 1 shared paper, 2023 · strength 0.18
  18. Jonathan G. Ragheb · 1 shared paper, 2023 · strength 0.18
  19. Prabhleen Chahal · 1 shared paper, 2023 · strength 0.18
  20. David L. Diehl · 1 shared paper, 2023 · strength 0.18
  21. Gong-Qing Shen · 1 shared paper, 2019 · strength 0.14
  22. Chao Tu · 1 shared paper, 2021 · strength 0.13
  23. Daniela S. Allende · 1 shared paper, 2019 · strength 0.11
  24. Davendra P. S. Sohal · 2 shared papers, 2014–2015 · strength 0.11
  25. Aryavarta M. S. Kumar · 1 shared paper, 2017 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.